XML 49 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies - Net Loss Per Share Table (Details) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Numerator [Abstract]                      
Net loss attributable to Inovio Pharmaceuticals, Inc. $ (7,411,404)us-gaap_NetIncomeLoss $ (7,177,575)us-gaap_NetIncomeLoss $ (10,711,274)us-gaap_NetIncomeLoss $ (10,821,460)us-gaap_NetIncomeLoss $ (15,454,330)us-gaap_NetIncomeLoss $ (30,877,410)us-gaap_NetIncomeLoss $ (10,852,588)us-gaap_NetIncomeLoss $ (8,844,120)us-gaap_NetIncomeLoss $ (36,121,713)us-gaap_NetIncomeLoss $ (66,028,448)us-gaap_NetIncomeLoss $ (19,668,955)us-gaap_NetIncomeLoss
Reflect adjustment for decrease in fair value of warrant liability                 (2,181,203)ino_AdjustmentforChangeinFairValueofWarrantLiability 0ino_AdjustmentforChangeinFairValueofWarrantLiability 0ino_AdjustmentforChangeinFairValueofWarrantLiability
Numerator for use in diluted loss per share                 $ (38,302,916)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (66,028,448)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (19,668,955)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Denominator [Abstract]                      
Weighted average number of common shares outstanding (shares) 60,610,367us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 60,392,911us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 60,232,498us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 55,159,002us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 52,127,419us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 47,989,039us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 44,988,704us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 39,038,883us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 59,127,349us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 46,087,773us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 34,127,312us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Effect of dilutive potential common shares from warrants (shares)                 280,903us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants 0us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants 0us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants
Denominator for use in diluted loss per share (shares) 60,805,871us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 60,602,831us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 60,474,859us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 55,159,002us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 52,127,419us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 47,989,039us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 44,988,704us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 39,038,883us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 59,408,252us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 46,087,773us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 34,127,312us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Earnings Per Share, Diluted ($ per share) $ (0.12)us-gaap_EarningsPerShareDiluted $ (0.12)us-gaap_EarningsPerShareDiluted $ (0.19)us-gaap_EarningsPerShareDiluted $ (0.20)us-gaap_EarningsPerShareDiluted $ (0.30)us-gaap_EarningsPerShareDiluted $ (0.64)us-gaap_EarningsPerShareDiluted $ (0.24)us-gaap_EarningsPerShareDiluted $ (0.23)us-gaap_EarningsPerShareDiluted $ (0.64)us-gaap_EarningsPerShareDiluted $ (1.43)us-gaap_EarningsPerShareDiluted $ (0.58)us-gaap_EarningsPerShareDiluted